Executive Summary
As care becomes more centered on the patient and the number of touchpoints and data inputs increases, care teams need a single pane view of the entire patient journey. In response, many health systems have begun to partner with a variety of CRM platforms such as Salesforce that have developed workflows and capabilities to meet the unique challenges of patient engagement and enable system-wide care traffic control. Bringing together data from parer apps and services, the platform gives the organization a shared view of the patient including medical history, insurance, scheduled appointments, preferences all in one place.
Hardly a day goes by without another new entrant declaring its foray into healthcare. Through a series of strategic acquisitions, Best Buy expanded from selling electronics and deploying its Geek Squad for repairs to providing home health services and remote monitoring. As the companys president suggested, achieving the goal of reducing healthcares spiraling costs will require some interesting new bedfellows.
Among these bedfellows is Lyft, which launched a healthcare-specific offering to reduce costly no-shows and remove transportation barriers for patients, especially those with chronic disease. Care teams can now order a ride in the same workflow as they do blood tests and, under some plans, have it covered by insurance. Then theres the explosion of apps, virtual consults and health chat bots making up the telemedicine market, which is expected to grow to $64 billion in the U.S. over the next five years.
What these trends point to is a dramatic expansion over the coming years of healthcares front door as the locus of care shifts from the hospital or clinic to patients themselves at work, home, or wherever their smartphones take them. Paired with a shift to value-based care and alignment of incentives to outcomes, this burst of innovation offers the promise of a more personalized approach to medicine focused on keeping patients well and out of the hospital, reducing overall cost of care. But it also brings with it some significant challenges that demand new approaches and safeguards.
Care traffic control
As care becomes more centered on the patient and the number of touchpoints and data inputs increases, care teams need a single pane view of the entire patient journey what John Halamka, executive director of the Health Technology Exploration Center of Beth Israel Lahey Health, has cleverly termed care traffic control. Orchestrating care and integrating data across an increasingly diverse and potentially virtualized care team requires new tools and what Halamka has called a new paradigm for team-based communication and wellness. Just as the retail industry has embraced knowledge sharing and omni-channel engagement through CRM platforms, so is healthcare recognizing the need for a coordinated approach to managing patient relationships.
In response, many health systems have begun to partner with a variety of CRM platforms that have developed workflows and capabilities to meet the unique challenges of patient engagement and enable system-wide care traffic control. For example, Piedmont Healthcare, a health system serving more than 2 million people across Georgia, partnered with Salesforce to help them deliver, engage and personalize care at scale. Bringing together data from partner apps and services, the platform gives the organization a shared view of the patient including medical history, insurance, scheduled appointments, preferences all in one place.
Piedmont care teams can get a more complete view of the patient by seeing medical history alongside information on employment, socioeconomic status, and other social determinants of health. In-home providers can access the same patient profiles to flag gaps around things like healthy food access or transportation that could land patients with chronic conditions back in the hospital. Armed with this data and the insights generated, outreach teams can send reminders or run targeted campaigns around things like nutrition classes to engage patients in more personalized ways. The ultimate goal is to deliver a more coordinated, tailored patient experience at a lower total cost of care.
While some might argue that EHRs can and should play this role of a unifying platform, most were never designed around patients and their full journey of care beyond the walls of a hospital or health system. Also, the average health system is challenged with integrating data and coordinating care across 18 different EHR systems across its various affiliated providers. A patient-relationship platform that sits atop these otherwise disconnected systems can provide a coordinated view of the patient journey thats otherwise sorely lacking.
Achieving the goal of truly personalized, patient-centered care still runs up against chronic and systemic interoperability challenges. But the expansion of digital health and the entry of Big Tech players such as Apple, Amazon and others have gradually shifted the calculus and created incentives for legacy EHR vendors and health systems to embrace a more open exchange of data. The rapid move across the industry to data-sharing via APIs using FHIR (Fast Healthcare Interoperability Resources) standards is a positive sign that the industrys information silos may finally be breaking down.
Navigating the healthcare data tsunami
Even with the right tools in place, coordinating patient care across an expanded and more diverse ecosystem will only get more challenging with the tsunami of data coming from these new sources. A recent International Data Corporation report predicts a 36% growth rate for healthcare data over the next five years, faster than in any other industry. With every month that passes, new smart medical devices appear and more app-using patients begin to monitor their health, expecting the resulting data to be sent to their doctors and EHRs. Early in 2019, the Centers for Medicare and Medicaid Services responded with a proposed rule calling on the healthcare industry to take steps to give patients safe, secure access to, and control over, their healthcare data.
But what does this actually mean? With no certification process in place for medical apps, how are newly empowered patients to choose which are trustworthy and effective? Likewise, what criteria are providers to use for prescribing apps or accepting and validating the data coming from them? As John Torous, MD, director of digital psychiatry at Beth Israel Deaconess Medical Center, has demonstrated, we have yet to figure out how to conduct randomized trials for apps the way we do for drugs. Thus, its hard to distinguish apps with therapeutic benefit from those that are just marketing hype. Along with questions of validation come equally important questions of usability. For the data from a validated app or device to be usable, rules need to be written to separate a signal from the noise for example, what heart rate patterns from a remotely monitored CHF patient get ignored and which trigger an alert to the EHR. Much more work is needed to wrestle with these thorny issues in order to effectively translate clinical skills into digital care delivery.
Finally, as empowering as it sounds to give patients control over their data, we know all too well from recent breaches and scandals how this opens up their data to exploitation. A recent study of 24 of the top medical apps available on the market found that 79% shared user data in ways that might compromise privacy. As data moves into patient hands, the traditional role of the physician as trusted gatekeeper begins to break down. If you share health information with your physician, she has privacy obligations. If you share it with Alexa or Google Home, the same privacy rules dont apply. We need to educate patients to the risk versus reward of these technologies and evolve data privacy regulations to match new realities.
Healthcare is at an inflection point, awkwardly poised between traditional care delivery models with their benefits and well-documented shortcomings and a wave of new, exciting but largely untested offerings and interventions. A healthy dose of skepticism and vigilance is needed as companies and investors look to ride the wave and seize near-term rewards. But the promise of more personalized, patient-centered and outcomes-based healthcare is real, worthy, and within reach.
See the rest here:
How New Health Care Platforms Will Improve Patient Care - Harvard Business Review
- Personalized medicine could transform healthcare - PMC - April 24th, 2025
- Genomic medicine and personalized treatment: a narrative review - April 24th, 2025
- Podcast: Ochre Bios Approach To Precision Medicine In Liver Treatment - insights.citeline.com - April 24th, 2025
- Reinforcement Learning in Personalized Medicine: A Comprehensive Review of Treatment Optimization Strategies - Cureus - April 24th, 2025
- Evolving Biomarkers: Charting the Future of Precision Medicine - MarketScale - April 24th, 2025
- Next Generation Tissue Biomarkers Market Size Report 2030 - Grand View Research - April 24th, 2025
- City of Hope Research on Artificial Intelligence (AI), Precision Medicine, Immunotherapies and Other Topics to be Presented at American Association of... - April 24th, 2025
- What the Newest mRNA Vaccines Could Do Beyond COVID - News-Medical - April 24th, 2025
- Opinion: Where public health ends and personalised medicine begins - Pulse+IT News - April 24th, 2025
- Crohns Disease Treatment Market to Reach $5.9 Billion by 2034, Driven by Biologics & Precision Medicine - Global Banking | Finance | Review - April 24th, 2025
- The Role of High Throughput Screening in Precision Medicine and Market Growth In New Report - WhaTech - April 24th, 2025
- Antiviral Chewing Gum May Prevent Flu and Herpes Transmission - Inside Precision Medicine - April 14th, 2025
- Wisconsin's role in the next advances in health care - BizTimes - April 14th, 2025
- The Future of Pulmonary Fibrosis Management: Precision Medicine, Biomarkers and AI - Managed Healthcare Executive - April 14th, 2025
- Leading Driver In The Jetrea Market 2025: Rise Of Personalized Medicine Fueling Growth - EIN News - March 9th, 2025
- Personalized Medicine Market Overview 2024-2025 & 2030: Oncology, Neurology, and Cardiology Lead Expansion, ext-Generation Sequencing and AI... - March 9th, 2025
- Innovations in core-shell nanoparticles advance drug delivery and precision medicine - Phys.org - March 9th, 2025
- Personalized Medicine: Motivation, Challenges and Progress - February 24th, 2025
- Healthcare innovations in predictive analytics, AI, and personalized medicine - HealthLeaders Media - February 24th, 2025
- Healthcare innovations in predictive analytics, AI, and personalized medicine - Fast Company - February 24th, 2025
- Artificial Intelligence (Ai) In Precision Medicine Market to See Robust Growth from USD 2.14 Billion to USD - EIN News - February 24th, 2025
- BMY: 3 Precision Medicine Stocks That Could Transform Healthcare - StockNews.com - February 24th, 2025
- Cracking Cancers Code: How Genetic Testing Is Changing the Treatment Game - geneonline - February 24th, 2025
- Curt Medeiros on Revolutionizing Precision Medicine and Scaling Ovation - Madrona Venture Group - January 6th, 2025
- Personalized medicine: The pros, cons and concerns - New Atlas - November 16th, 2024
- Precision Medicine, AI, and the Future of Personalized Health Care - November 16th, 2024
- Why precision medicine results in more effective health care, treatment plans - The Business Journals - November 16th, 2024
- Comprehensive Genomic Profiling at Diagnosis Extends Survival in Patients with Advanced Cancer - Inside Precision Medicine - November 16th, 2024
- More Precise Classifications of NonClear Cell RCC Are Required to Improve Personalized Treatment - OncLive - September 13th, 2024
- Bahrain aims to provide residents with personalized healthcare - Healthcare IT News - September 13th, 2024
- Precision Medicine Market Is Expected To Reach Revenue Of - GlobeNewswire - September 13th, 2024
- New Graduates Leverage Genomics Education in Clinical and Research Settings - University of Colorado Anschutz Medical Campus - June 20th, 2024
- Personalized medicine is coming, but who will have access to it? - March 10th, 2024
- Personalized medicine | Definition, Origins, Examples, & Ethical ... - March 10th, 2024
- Innovating for Individual Care: The Impact of USP on Personalized Medicine - March 10th, 2024
- Live Cell Encapsulation Market To Reach USD 313.3 Million at a CAGR of 4% in 2032 - EIN News - April 23rd, 2023
- Cancer Therapeutics and Biotherapeutics Market is estimated to be US$ 506.8 billion by 2032 with a CAGR of - EIN News - April 7th, 2023
- Regenerative Therapies Market is Set to Grow at a CAGR of 8.7% by 2033, Propelled by Advancements in - EIN News - March 13th, 2023
- Gene Therapy Market Size (USD 46.5 Bn by 2030): A Growing Industry and Its Impact on Healthcare Systems - EIN News - March 13th, 2023
- Translating the Microbiome - Inside Precision Medicine - October 15th, 2022
- Enhancing Enrollment in Biomarker-Driven Oncology and Rare Disease Trials - Applied Clinical Trials Online - October 15th, 2022
- Global Cancer/Tumor Profiling Market Research Report to 2027 - Increasing Demand for Personalized Medicine Presents Opportunities -... - October 15th, 2022
- Cambridge biotech raises $168 million to fight cancer and other diseases - The Boston Globe - October 15th, 2022
- Perlmutter Cancer Center Medical Oncologist Provides Personalized Care to People with Breast Cancer - NYU Langone Health - October 15th, 2022
- Concierge Medicine's Continued Rise Illuminated by Specialdocs Consultants at the Industry's Leading Event - PR Newswire - October 15th, 2022
- Hormone Changes: The Star of Every Stage in Women's Sleep - Medscape - October 15th, 2022
- Could Xolair Be the First Biologic Treatment for Food Allergies? - Allergic Living - October 15th, 2022
- Matching Treatments to Your Genes - The Epoch Times - October 15th, 2022
- Global Monoclonal Antibodies (mAbs) Markets, 2018-2021 & 2022-2030 - Increasing R&D Activities Aimed at the Development of Novel Therapeutic mAbs -... - October 15th, 2022
- Xcell Biosciences and aCGT Vector Collaborate to Accelerate Development of Cell and Gene Therapies - Business Wire - October 15th, 2022
- Learn Look Locate Partners with Genetic Testing Leader, Myriad Genetics, in Educational Campaign - PR Newswire - October 15th, 2022
- Important Mission By LG To Reinvent Society With Future Growth - Forbes - October 15th, 2022
- Scientists identify more than 12,000 spots in the human genome associated with height - Inverse - October 15th, 2022
- The future of cancer research | News - ND Newswire - October 15th, 2022
- Kyverna Therapeutics Names Peter Maag, Ph.D., as Chief Executive Officer - PR Newswire - October 15th, 2022
- Call for Accurate Automation in Healthcare Practices to drive the Laboratory Information Systems (LIS) Market | Future Market Insights, Inc. - Yahoo... - October 15th, 2022
- Stem Cell Manufacturing Global Market Report 2022: Widespread Product Utilization in Effective Disease Ma - Benzinga - October 15th, 2022
- Global Precision Medicine Software Market is projected to witness a healthy growth rate of 10% in the upcoming years - Bio-IT World - July 17th, 2022
- The Single-Cell Analysis Market Size To Almost Double By 2026 Due To A Rising Focus On Personalized Medicine As Per The Business Research Company's... - July 17th, 2022
- Northwell Health Partners with Google Cloud to Provide Proactive, Personalized Healthcare - PR Newswire - July 17th, 2022
- Leveraging whole blood based functional flow cytometry assays to open new perspectives for rheumatoid arthritis translational research | Scientific... - July 17th, 2022
- New Approaches Needed To Support Digitization Of Healthcare - Forbes - July 17th, 2022
- Outlook on the Microtome Global Market to 2027 - Increasing Demand for Personalized Medicine Presents Opp - Benzinga - July 17th, 2022
- Precision health perspectives - UCI News - July 17th, 2022
- The Worldwide Compound Management Industry is Expected to Reach $1.4 Billion by 2030 - ResearchAndMarkets.com - Business Wire - July 17th, 2022
- Thrive Pet Healthcare and FidoCure Announce An Expansive Pet Precision Health Partnership - Benzinga - Benzinga - July 17th, 2022
- Access to Myriad Genetics GeneSight Test Improves Depression Remission Rates In Largest Ever Mental Health PGx Randomized Controlled Trial - Yahoo... - July 17th, 2022
- Global Induced Pluripotent Stem Cell (iPSC) Market Report 2022: Rising Applications of iPSCs Fueling Industry Growth - ResearchAndMarkets.com -... - July 17th, 2022
- Research Antibodies and Reagents Market worth $16.1 Billion by 2027 Exclusive Report by MarketsandMarkets - Yahoo Finance - July 17th, 2022
- Global Custom Antibody Market Is Expected To Reach USD 742.27 Million At A CAGR Of 10.3% And Forecast To 2029 - Digital Journal - July 17th, 2022
- Personalized Medicine Coalition - Precision Medicine Advocacy and ... - June 8th, 2022
- Precision Medicine | FDA - June 8th, 2022
- Global Precision Medicine Software Market is anticipated to witness a lucrative CAGR of 10% - GlobeNewswire - June 8th, 2022
- Global Biomarkers Markets Research 2022-2027: Increased Adoption of Biomarkers in Personalized Medicine / Focus on Digital Biomarkers / Increased... - June 8th, 2022
- Every patient in this experimental drug trial saw their cancer disappear, researchers say - CBS News - June 8th, 2022
- The Middle East molecular diagnostics market is projected to reach $1,017.7 million by 2031 from $493.1 million in 2020, at a CAGR of 6.72% during the... - June 8th, 2022
- It's time to move past Aduhelm and focus on a broader Alzheimer's drug pipeline - STAT - June 8th, 2022
- Can the industry elevate the success rate of cancer trials? - OutSourcing-Pharma.com - June 8th, 2022
- Purdue Polytechnic Institute and Purdue University Global collaborating on partnership with the University of Puerto Rico - Purdue University - June 8th, 2022
- Illumina Announces Next Generation Products and Data at AGBT General Meeting to Advance Innovative Customer Solutions - PR Newswire - June 8th, 2022